Functional Characterization of Adenosine Receptors in the Nucleus Tractus Solitarius Mediating Hypotensive Responses in the Rat

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1996 Jan 1

PMID 8789383

Citations 4

Authors

P J White

R B RoseMeyer

W Hope

Affiliations

Soon will be listed here.

Abstract

1. The aim of this study was to characterize adenosine receptors located in the nucleus tractus solitarius (NTS) that mediate decreases in blood pressure in the anaesthetized rat. To determine the adenosine receptor subtype involved, a range of selective agonists and antagonists were studied and their relative potencies evaluated. 2. The rank order of agonist potency in inducing decreases in diastolic blood pressure was N6-cyclopentyladenosine (CPA) > N6-cyclohexyladenosine (CHA) > N-ethyl-carboxamidoadenosine (NECA) > or = 2-phenylaminoadenosine (CV1808) > 2-p-(carboxyethyl)phenethylamino-5' N-ethylcarboxamidoadenosine (CGS 21680) > N6-(2-(4-aminophenyl)ethyl)-adenosine (APNEA). 3. The hypotensive action of CPA following microinjection into the NTS was antagonized by i.v. infusions (50 micrograms kg-1 min-1) of adenosine receptor antagonists, 8-cyclopentyl-1,3 dipropylxanthine (DPCPX), 8-phenyltheophylline (8-PT), 8-(p-sulphophenyl)theophylline (8-SPT), and 1,3-dipropyl-8-N-(2-diethylamino)ethyl)-N methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo) benzenesulphonamidexanthine (PD 115199). The antagonist potency order was DPCPX > PD115199 > or = 8-PT. Intravenous infusion of 8-SPT had no effect on blood pressure responses to microinjection of CPA into the NTS. 4. The results suggest that adenosine A1 receptors in the NTS mediate hypotensive responses in the anaesthetized rat preparation.

Citing Articles

Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy.

Wolska N, Rozalski M Int J Mol Sci. 2019; 20(21).

PMID: 31684173 PMC: 6862090. DOI: 10.3390/ijms20215475.

Adenosine A2A receptors modulate acute injury and neuroinflammation in brain ischemia.

Pedata F, Pugliese A, Coppi E, Dettori I, Maraula G, Cellai L Mediators Inflamm. 2014; 2014:805198.

PMID: 25165414 PMC: 4138795. DOI: 10.1155/2014/805198.

The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices.

Pugliese A, Traini C, Cipriani S, Gianfriddo M, Mello T, Giovannini M Br J Pharmacol. 2009; 157(5):818-30.

PMID: 19422385 PMC: 2721266. DOI: 10.1111/j.1476-5381.2009.00218.x.

The adenosine A1 receptor agonist adenosine amine congener exerts a neuroprotective effect against the development of striatal lesions and motor impairments in the 3-nitropropionic acid model of neurotoxicity.

Blum D, Gall D, Galas M, dAlcantara P, Bantubungi K, Schiffmann S J Neurosci. 2002; 22(20):9122-33.

PMID: 12388620 PMC: 6757706.

References

Collis M, Hourani S . Adenosine receptor subtypes. Trends Pharmacol Sci. 1993; 14(10):360-6. DOI: 10.1016/0165-6147(93)90094-z. View

Tao S, Abdel-Rahman A . Neuronal and cardiovascular responses to adenosine microinjection into the nucleus tractus solitarius. Brain Res Bull. 1993; 32(4):407-17. DOI: 10.1016/0361-9230(93)90208-s. View

St Lambert J, Dawid-Milner M, Silva-Carvalho L, Spyer K . Action of adenosine receptor antagonists on the cardiovascular response to defence area stimulation in the rat. Br J Pharmacol. 1994; 113(1):159-64. PMC: 1510067. DOI: 10.1111/j.1476-5381.1994.tb16188.x. View

von Kugelgen I, Spath L, Starke K . Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br J Pharmacol. 1994; 113(3):815-22. PMC: 1510427. DOI: 10.1111/j.1476-5381.1994.tb17066.x. View

van Calker D, Muller M, Hamprecht B . Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J Neurochem. 1979; 33(5):999-1005. DOI: 10.1111/j.1471-4159.1979.tb05236.x. View

Kamikawa Y, Cline Jr W, Su C . Diminished purinergic modulation of the vascular adrenergic neurotransmission in spontaneously hypertensive rats. Eur J Pharmacol. 1980; 66(4):347-53. DOI: 10.1016/0014-2999(80)90467-7. View

Daly J, Butts-Lamb P, Padgett W . Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell Mol Neurobiol. 1983; 3(1):69-80. PMC: 11572908. DOI: 10.1007/BF00734999. View

Bruns R, Lu G, Pugsley T . Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol. 1986; 29(4):331-46. View

Evoniuk G, von Borstel R, Wurtman R . Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline. J Pharmacol Exp Ther. 1987; 240(2):428-32. View

10.

Williams M . Adenosine antagonists. Med Res Rev. 1989; 9(2):219-43. DOI: 10.1002/med.2610090205. View

11.

Matias A, Albino-Teixeira A, Polonia J, Azevedo I . Long-term administration of 1,3-dipropyl-8-sulfophenylxanthine causes arterial hypertension. Eur J Pharmacol. 1991; 193(1):101-4. DOI: 10.1016/0014-2999(91)90206-6. View

12.

Barraco R, Phillis J . Subtypes of adenosine receptors in the brainstem mediate opposite blood pressure responses. Neuropharmacology. 1991; 30(4):403-7. DOI: 10.1016/0028-3908(91)90067-l. View

13.

Rabkin S . D-Ala-2-Me-Phe-4-Met-(O)-ol-enkephalin in the nucleus tractus solitarius of the rat produces cardiorespiratory depression. Gen Pharmacol. 1991; 22(3):479-84. DOI: 10.1016/0306-3623(91)90009-u. View

14.

Tseng C, Appalsamy M, Beck C, Robertson D . Cardiovascular excitatory effects of adenosine in the nucleus of the solitary tract. Hypertension. 1991; 18(4):494-502. DOI: 10.1161/01.hyp.18.4.494. View

15.

Talman W, Lewis S . Altered cardiovascular responses to glutamate and acetylcholine microinjected into the nucleus tractus solitarii of the SHR. Clin Exp Hypertens A. 1991; 13(5):661-8. DOI: 10.3109/10641969109042069. View

16.

Zhou Q, Li C, Olah M, Johnson R, Stiles G, Civelli O . Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci U S A. 1992; 89(16):7432-6. PMC: 49724. DOI: 10.1073/pnas.89.16.7432. View

17.

Ferre S, Fuxe K, von Euler G, Johansson B, Fredholm B . Adenosine-dopamine interactions in the brain. Neuroscience. 1992; 51(3):501-12. DOI: 10.1016/0306-4522(92)90291-9. View

18.

Mathot R, van Schaick E, Langemeijer M, Soudijn W, Breimer D, IJzerman A . Pharmacokinetic-pharmacodynamic relationship of the cardiovascular effects of adenosine A1 receptor agonist N6-cyclopentyladenosine in the rat. J Pharmacol Exp Ther. 1994; 268(2):616-24. View